{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:20:15Z","timestamp":1788477615555,"version":"build-2803163510"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To explore the pharmacological mechanisms of Chongcaoyishen decoction (CCYSD) against chronic kidney disease (CKD) <jats:italic>via<\/jats:italic> network pharmacology analysis combined with experimental validation.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The bioactive components and potential regulatory targets of CCYSD were extracted from the TCMSP database, and the putative CKD-related target proteins were collected from the GeneCards and OMIM database. We matched the active ingredients with gene targets and conducted regulatory networks through Perl5 and R 3.6.1. The network visualization analysis was performed by Cytoscape 3.7.1, which contains ClueGO plug-in for GO and KEGG analysis. <jats:italic>In vivo<\/jats:italic> experiments were performed on 40 male SD rats, which were randomly divided into the control group (<jats:italic>n<\/jats:italic> = 10), sham group (<jats:italic>n<\/jats:italic> = 10), UUO group (<jats:italic>n<\/jats:italic> = 10), and CCYSD group (<jats:italic>n<\/jats:italic> = 10). A tubulointerstitial fibrosis model was constructed by unilateral ureteral obstruction through surgery and treated for seven consecutive days with CCYSD (0.00657\u00a0g\/g\/d). At the end of treatment, the rats were euthanized and the serum and kidney were collected for further detection.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In total, 53 chemical compounds from CCYSD were identified and 12,348 CKD-related targets were collected from the OMIM and GeneCards. A total of 130 shared targets of CCYSD and CKD were acquired by Venn diagram analysis. Functional enrichment analysis suggested that CCYSD might exert its pharmacological effects in multiple biological processes, including oxidative stress, apoptosis, inflammatory response, autophagy, and fiber synthesis, and the potential targets might be associated with JAK-STAT and PI3K-AKT, as well as other signaling pathways. The results of the experiments revealed that the oxidative stress in the UUO group was significantly higher than that in normal state and was accompanied by severe tubulointerstitial fibrosis (TIF), which could be effectively reversed by CCYSD (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Meanwhile, aggravated mitochondrial injury and autophagy was observed in the epithelial cells of the renal tubule in the UUO group, compared to the normal ones (<jats:italic>p<\/jats:italic> &amp;lt; 0.05), while the intervention of CCYSD could further activate the autophagy and reduce the mitochondrial injury (<jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> We provide an integrative network pharmacology approach combined with <jats:italic>in vivo<\/jats:italic> experiments to explore the underlying mechanisms governing the CCYSD treatment of CKD, which indicates that the relationship between CCYSD and CKD is related to its activation of autophagy, promotion of mitochondrial degradation, and reduction of tissue oxidative stress injury, promoting the explanation and understanding of the biological mechanism of CCYSD in the treatment of CKD.<\/jats:p>","DOI":"10.3389\/fmolb.2022.847812","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:59:53Z","timestamp":1648724393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Chongcaoyishen Decoction Against Chronic Kidney Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhenliang","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaorui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00210-019-01759-3","article-title":"Effects of Single and Dual RAAS Blockade Therapy on Progressive Kidney Disease Transition to CKD in Rats","volume":"393","author":"Aggarwal","year":"2020","journal-title":"Naunyn-schmiedeberg's Arch. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2011.11.015","article-title":"'United States Renal Data System 2011 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States","author":"Collins","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The Contribution of Chronic Kidney Disease to the Global burden of Major Noncommunicable Diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","article-title":"Cellular and Molecular Mechanisms of Kidney Fibrosis","volume":"65","author":"Djudjaj","year":"2019","journal-title":"Mol. aspects Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3969\/j.issn.1008-0805.2019.10.001","article-title":"Effects of Cordycepin and Hirudin on Inflammatory Response, EMT and RIF in UUO Rats [J]","volume":"30","author":"Fan","year":"2019","journal-title":"Shi Zhen Traditional Chin. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","article-title":"Renal Fibrosis: Primacy of the Proximal Tubule","author":"Gewin","year":"2018","journal-title":"Matrix Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD): Advances in Pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"key":"B8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of Renal Fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"B9","volume-title":"Using Differential Protein Group to Study the Effect of Cordyceps Sinensis Yishi Formula on Renal Tissue in Unilateral Ureteral Obstruction Rats [D]","author":"Jie","year":"2015"},{"key":"B10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3969\/j.issn.1006-2084.2020.03.034","article-title":"Effect of Cordyceps Yishen Prescription on Wnt\/\u03b2 -binding Signaling Pathway in Unilateral Ureteral Obstruction Rats [J]","volume":"26","author":"Ma","year":"2020","journal-title":"Med. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.13194\/j.issn.1673-842x.2019.07.011","article-title":"Effects of Cordyceps Yishen Prescription on Notch1 and Related microRNA Expression in UUO Rats [J]","volume":"21","author":"Mo","year":"","journal-title":"J. Liaoning Univ. Traditional Chin. Med."},{"key":"B15","first-page":"39","article-title":"Effects of Cordyceps Sinensis Yishen Formula on Notch Signaling Pathway in Unilateral Ureteral Obstruction Rats [J]","volume":"37","author":"Mo","year":"","journal-title":"Sichuan Traditional Chin. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update","volume":"60","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"F753","DOI":"10.1152\/ajprenal.00528.2017","article-title":"Klotho and Activin A in Kidney Injury: Plasma Klotho Is Maintained in Unilateral Obstruction Despite No Upregulation of Klotho Biosynthesis in the Contralateral Kidney","volume":"314","author":"Nordholm","year":"2018","journal-title":"Am. J. Physiology-Renal Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1159\/000495678","article-title":"1,25-Dihydroxyvitamin D3 Attenuates Angiotensin II-Induced Renal Injury by Inhibiting Mitochondrial Dysfunction and Autophagy","volume":"51","author":"Shen","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/s0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"The Lancet"},{"key":"B17","volume-title":"Study on the Effect of Cordyceps Yishen Granule on Megsin and p38MAPK Signaling Pathway in Human Glomerular Mesangial Cells [D]","author":"Zhang","year":"2016"},{"key":"B18","volume-title":"Effect of Cordyceps Yishen Prescription on Sonic Hedgehog Signaling Pathway in Renal Tissue of Unilateral Ureteral Obstruction Rats [D]","author":"Ziyang","year":"2019"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.847812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:00:01Z","timestamp":1648724401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.847812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":18,"alternative-id":["10.3389\/fmolb.2022.847812"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.847812","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"847812"}}